Cargando…

Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer

BACKGROUND: CKLF Like MARVEL Transmembrane Domain Containing 6 (CMTM6) is involved in the epigenetic regulation of genes and tumorigenesis. Programmed cell death ligand 1 (PD-L1) is closely related to the prognosis of some human cancers. CMTM6 is a key regulator of PD-L1 in many cancers. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chao, Zhao, Shutao, Wang, Xudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842018/ https://www.ncbi.nlm.nih.gov/pubmed/33509216 http://dx.doi.org/10.1186/s12935-020-01734-6

Ejemplares similares

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
por: Mezzadra, Riccardo, et al.
Publicado: (2017)

CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
por: Zhang, Tong, et al.
Publicado: (2022)

Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers
por: Takeuchi, Hiroto, et al.
Publicado: (2020)

CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients
por: Li, Xin, et al.
Publicado: (2020)

Analysis of CMTM6 and CMTM4 expression as potential regulators of the PD-L1 protein and its association with prognosis in glioma cancer
por: Xue, Hui, et al.
Publicado: (2022)

CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
por: Yugawa, Kyohei, et al.
Publicado: (2020)

CMTM6 and CMTM7: New leads for PD‐L1 regulation in breast cancer cells undergoing EMT
por: Xiao, Malina, et al.
Publicado: (2022)

CMTM6, the newly identified PD-L1 regulator, correlates with PD-L1 expression in lung cancers
por: Gao, Feng, et al.
Publicado: (2019)

Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer
por: Xiao, Malina, et al.
Publicado: (2021)

Expression and Clinical Significance of CMTM6 and PD-L1 in Triple-Negative Breast Cancer
por: Shi, Shuai, et al.
Publicado: (2022)

The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer
por: Tian, Yiping, et al.
Publicado: (2021)

Co-Expression with Membrane CMTM6/4 on Tumor Epithelium Enhances the Prediction Value of PD-L1 on Anti-PD-1/L1 Therapeutic Efficacy in Gastric Adenocarcinoma
por: Wang, Ziqi, et al.
Publicado: (2021)

The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
por: Huang, Zi-Lu, et al.
Publicado: (2019)

Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma
por: Liu, Li-Li, et al.
Publicado: (2020)

Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment
por: Zhao, Yanbin, et al.
Publicado: (2021)

CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling
por: Xu, Gang, et al.
Publicado: (2017)

CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway
por: Yuan, Wanqiong, et al.
Publicado: (2021)

Conditional survival after surgical resection of primary retroperitoneal tumors: a population-based study
por: Zhao, Shutao, et al.
Publicado: (2021)

CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer
por: Wu, Xuehui, et al.
Publicado: (2021)

Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1–Independent Manner
por: Long, Yiru, et al.
Publicado: (2023)

Adipocytes promote tumor progression and induce PD-L1 expression via TNF-α/IL-6 signaling
por: Li, Zhi, et al.
Publicado: (2020)

Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer
por: Ren, Qianqian, et al.
Publicado: (2020)

CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1
por: Zeisbrich, Markus, et al.
Publicado: (2021)

Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
por: Li, Kang, et al.
Publicado: (2022)

CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer
por: Peng, Qi-Hua, et al.
Publicado: (2021)

HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer
por: Liu, Yanbin, et al.
Publicado: (2021)

Expression and prognostic potential of ribosome 18S RNA m(6)A methyltransferase METTL5 in gastric cancer
por: Wang, Zhenshuang, et al.
Publicado: (2021)

PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancer
por: Jiang, Cui, et al.
Publicado: (2019)

miR-502-5p affects gastric cancer progression by targeting PD-L1
por: You, Wendao, et al.
Publicado: (2020)

A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients
por: Yang, Jing, et al.
Publicado: (2020)

Increased expression of TAZ and associated upregulation of PD-L1 in cervical cancer
por: Han, Yanyan, et al.
Publicado: (2021)

Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
por: Liu, Gao-Min, et al.
Publicado: (2019)

Seven novel glucose-6-phosphate dehydrogenase (G6PD) deficiency variants identified in the Qatari population
por: Malik, Shaza, et al.
Publicado: (2021)

A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer
por: Liu, Lei, et al.
Publicado: (2021)

Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer
por: Dong, Hao, et al.
Publicado: (2023)

A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer
por: Li, Chunmei, et al.
Publicado: (2020)

Elevated PD-L1 expression predicts poor survival outcomes in patients with cervical cancer
por: Gu, Xiaobin, et al.
Publicado: (2019)

Prognostic Nomogram for Early Gastric Cancer After Surgery to Assist Decision-Making for Treatment With Adjuvant Chemotherapy
por: Zhang, Chao, et al.
Publicado: (2022)

Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma
por: Tan, Shengkui, et al.
Publicado: (2022)

High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence
por: Muranushi, Ryo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vnfb0vjr6b0ejrsopfgs55nciu